Wheezing Illness in Children with Asthma Aged 1.5 to 4 Years After Live Attenuated Influenza Vaccine (LAIV), Central Texas Field Trial, 1998-2002 Pedro.

Slides:



Advertisements
Similar presentations
FLU SEASON IMPORTANT FACTS.
Advertisements

Duration of Serum Antibody Response to Seasonal Influenza Vaccines: Summary The level of antibody response made to seasonal influenza vaccines depends.
Network 8, Inc. 5 Diamond Patient Safety Program Influenza Vaccination
Case Study MICR 420 Emerging and Re-Emerging Infectious Diseases S2010 Case 10 Jessica Cisneros Susana Hernandez.
JOURNAL CLUB M M Khan ST6. 4 year 2 nd wheezy episode O/E mild distress. Sats borderline Management : Salbutamol Ipratropium bromide Steroid.
Influenza and Influenza Vaccine
DO HEALTHY CHILDREN NEED TO GET VACCINATED?. Rationale for childhood vaccination Annual influenza vaccine is widely recommended for children at high risk.
INFLUENZA (FLU) Management Presentation
Puja A. Sehgal, MD Kelsey-Seybold Clinic
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
Child Health Disparities Denice Cora-Bramble, MD, MBA Professor of Pediatrics, George Washington University Executive Director Goldberg Center for Community.
OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD Pediatric Pulmonology Unit, Sleep Disorders Laboratory First Department.
Dr. Simon Benson GP Specialist Trainee. Introduction Diagnosis of pneumonia in children with wheeze is difficult Limited data exists regarding predictors.
Update on Acute Asthma Carlos Camargo, MD, DrPH Emergency Medicine, MGH Channing Laboratory, BWH Harvard Medical School
Noreen Clark, PhD Molly Gong, MD Julie Dodge, MS Sijian Wang, M.S. Xihong Lin, PhD William Bria, MD Timothy Johnson, MD University of Michigan School of.
National Vaccine Advisory Committee November 29, 2005 Update on NIH H5N1 Vaccine Trials Linda C. Lambert Chief, Respiratory Diseases Branch Division of.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Nebulized Hypertonic Saline for Bronchiolitis Florin TA, Shaw KN, Kittick M, Yakscoe.
Influenza Vaccination
Asthma What is Asthma ? V1.0 1997 Merck & ..
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
ESRD Network 6 5 Diamond Patient Safety Program
Inhaled corticosteroids in preschool asthmatic children
Asthma: Shared Medical Appointments
Copyright restrictions may apply A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency.
Introduction Background : Asthma is a common chronic airway disorder characterized by periods of reversible airflow obstruction known as asthma attack.
Asthma exacerbations can be treated in multiple ways. Typically, an inhaled bronchodilator will be administered via nebulizer or MDI. Nebulizers have been.
Updated ACIP Recommendations for Using Hepatitis A Vaccine for Postexposure and International Travel Management Miriam J. Alter, Ph.D., MPH Infectious.
Neonates (children less than one month of age) have immature immune systems and are at higher risk for serious complications of bacterial and viral infections,
Surveillance for Asthma: Measuring a Moving Target David M. Mannino Air Pollution and Respiratory Health Branch Centers for Disease Control and Prevention.
CHI CAGO The Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO Trial) Valerie Press, MD, MPH Assistant Professor, Section.
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group,
PIDPIC SOT Working Group Pediatric Infectious Diseases Program for Immunocompromised Hosts.
The Introduction of Allergenic Foods and the Development of Reported Wheezing and Eczema in Childhood: The Generation R Study Tromp IIM, Kiefte-de Jong.
Enterovirus D68 Illness in Hospitalized Children under 24 Months of Age Kayla B. Briggs 1, Rangaraj Selvarangan 2, Ferdaus Hassan 2, Mary Anne Jackson.
OBSTRUCTIVE SLEEP DISORDERS IN BREATHING IN CHILDHOOD Adenotonsillar Hypertrophy A. Kaditis, MD Pediatric Pulmonology Unit, Sleep Disorders Laboratory.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye, MD PGY-3 September 15, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Influenza Prevention and Treatment for the Season Faculty Stefan Gravenstein, MD, MPH Professor of Medicine The Center for Geriatric Medicine.
1 Vaccines and Related Biologic Products Advisory Committee (VRBPAC) May 16, 2007 FluMist ® Influenza Virus Vaccine Live, Intranasal Safety and Effectiveness.
By: Sarah Lombardi Is the Influenza Vaccination in the Geriatric Population Needed?
Samar Musmar,MD,FAAFP Vice Dean for Clinical Affairs An-Najah National University Faculty of Medicine Head, Medicine and Society Dep. Flu Vaccination in.
Diagnosing and Staging Asthma*
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
Herd Protection against Influenza W P Glezen, P A Piedra, M J Gaglani SCOTT & WHITE Clinic and Houston, Texas Temple, Texas.
Bronchiolitis Abdullah M. Al-Olayan MBBS, SBP, ABP. Assistant Professor of Pediatrics. Pediatric Pulmonologist.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Food and Drug Administration Division of Pulmonary and Allergy Drug Products Summary Comments - Orally Inhaled and Intranasal Budesonide and Fluticasone.
Advances in Pediatric Asthma Care Keyvan Rafei, MD, MBA Division Head, Pediatric Emergency Medicine Chairman, Pediatric Asthma Program.
Long-term Mortality Among Adults With Asthma A 25-Year Follow-up of 1,075 Outpatients With Asthma Zarqa Ali, MD; Christina Glattre Dirks, MD, PhD; and.
HERD PROTECTION BY IMMUNIZATION W. Paul Glezen, M.D.
Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health – Dr Mazen.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
1 Review of the Evidence: Risk for Wheezing after Live, Attenuated Influenza Vaccine (LAIV: FluMist ® ) in Children Aged 2–4 Years Karen R. Broder, MD.
Vaccination Recommendations Sepehr Khashaei Assistant Professor of Internal Medicine.
The Impact of Asthma Education CHKV Medical Mission 2011 By Jo-Anne St. Vincent Jo-Anne St. Vincent.
Adolescent Vaccination: Taking It to the Schools Immunization Site Preferences Among Primarily Hispanic Middle School Parents Amy B. Middleman, MD, MSEd,
Symptoms of allergic rhinitis
(SHRIMP SENSITIZED ON AIT) 5 failed OFC + 5 w/ hx of anaphylaxis
Texas Regional Template: CLABSI Workgroup Organization: [enter here]
Influenza Vaccine Effectiveness Against Pediatric Deaths:
Bronchiolitis Clinical Practice Guideline QI Project
The Texas Regional Hospitals
Evidence-Based Asthma Guidelines
U.S. Influenza Sentinel Provider Surveillance Network
Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children  Paul J. Turner, FRACP,
Asthma, influenza, and vaccination
School-Based Immunization for Control of Influenza?
Provider Counseling for Immunizations in Primary Care Settings
Presentation transcript:

Wheezing Illness in Children with Asthma Aged 1.5 to 4 Years After Live Attenuated Influenza Vaccine (LAIV), Central Texas Field Trial, Pedro A. Piedra, MD W. Paul Glezen, MD Baylor College of Medicine, Houston, Texas Manjusha J. Gaglani, MBBS Mark Riggs, PhD Scott & White Memorial Hospital and Clinic TAMU Health Science Center, Temple, Texas

Criteria for LAIV on enrollment in the Trial Piedra et al: Pediatrics 2005; 116:e397-e407 Healthy Children, 1.5 to 18 years of age, without immunocompromized household contact Children with mild intermittent asthma were included Definition: Mild intermittent asthma was defined as history of asthma or reactive airway disease (RAD) not requiring daily (or every other day) use of steroids (oral or inhaled) or bronchodilator therapy for asthma control, not hospitalized or seen in the emergency room for asthma in the prior 12 months (prior 6 months if they were < 2 years old). Children with exercise-induced asthma were included. Children with allergic rhinitis on daily nasal steroids were included. [Others were offered inactivated influenza vaccine if not allergic to eggs.]

Year years of age RAD*No RAD Pre-School Children with a History of Asthma/Reactivate Airway Disease (RAD) Who Received the Live Attenuated Influenza Vaccine (LAIV) in the Central Texas Field Trial, Scott & White Clinic (SWC) *identified by parent history, medical record or both (about 1/3 in each group)

Relative Risk of Medically Attended Acute Respiratory Illness (MAARI) Days after LAIV for Children 1.5 – 4 Years of Age with RAD, Central Texas Field Trial, Year 1 – 14 days post-LAIV*Pre-LAIV & >14 Days RR Post-LAIV (reference)*95% CI , , , , 0.81 *Rate per 10,000 child-days

Relative Risk of Lower Respiratory Illness (LRI) 1 – 14 Days after LAIV for Children 1.5 – 4 Years of Age with RAD, Central Texas Field Trial, 1998 – Year 1 – 14 days post-LAIV*Pre-LAIV & >14 Days RR Post-LAIV (reference)*95% CI , , , n/a *Rate per 10,000 child-days

Relative Risk of Asthma/RAD Events 1 – 14 Days after LAIV for Children 1.5 – 4 Years of Age with RAD Central Texas Field Trial, 1998 – Year 1 – 14 days post-LAIV*Pre-LAIV & >14 Days RR Post-LAIV (reference)*95% CI , , , n/a *Rate per 10,000 child-days

Relative Risk of Medically Attended Acute Respiratory Illness (MAARI) 1 – 42 Days after LAIV for Children 1.5 – 4 Years of Age with RAD Central Texas Field Trial, 1998 – Year 1 – 42 days post-LAIV*Pre-LAIV & >42 Days RR Post-LAIV (reference)*95% CI , , , , 0.93 *Rate per 10,000 child-days

Relative Risk of Lower Respiratory Illness (LRI) 1 – 42 Days after LAIV for Children 1.5 – 4 Years of Age with RAD Central Texas Field Trial, 1998 – Year 1 – 42 days post-LAIV*Pre-LAIV & >42 Days RR Post-LAIV (reference)*95% CI , , , , 1.06 *Rate per 10,000 child-days

Relative Risk of Asthma/Reactive Airways Disease (RAD) 1 – 42 Days after LAIV for Children 1.5 – 4 Years of Age with RAD, Central Texas Field Trial, 1998 – Year 1 – 42 days post-LAIV*Pre-LAIV & >42 Days RR Post-LAIV (reference)*95% CI , , , n/a *Rate per 10,000 child-days